nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—SLC22A3—prostate cancer	0.156	0.582	CbGaD
Metformin—SLC22A1—prostate cancer	0.112	0.418	CbGaD
Metformin—NDUFS2—Doxorubicin—prostate cancer	0.0812	0.241	CbGbCtD
Metformin—NDUFS3—Doxorubicin—prostate cancer	0.0812	0.241	CbGbCtD
Metformin—NDUFS7—Doxorubicin—prostate cancer	0.0812	0.241	CbGbCtD
Metformin—SLC47A1—Mitoxantrone—prostate cancer	0.045	0.134	CbGbCtD
Metformin—SLC22A3—Estradiol—prostate cancer	0.0227	0.0675	CbGbCtD
Metformin—SLC22A2—Estradiol—prostate cancer	0.0135	0.04	CbGbCtD
Metformin—SLC22A1—Estradiol—prostate cancer	0.0117	0.0347	CbGbCtD
Metformin—NDUFA2—Podofilox—Etoposide—prostate cancer	0.00151	0.738	CbGdCrCtD
Metformin—NDUFC1—seminal vesicle—prostate cancer	0.000585	0.0049	CbGeAlD
Metformin—NDUFAF1—seminal vesicle—prostate cancer	0.000575	0.00482	CbGeAlD
Metformin—NDUFV2—renal system—prostate cancer	0.000575	0.00482	CbGeAlD
Metformin—NDUFB3—seminal vesicle—prostate cancer	0.000566	0.00474	CbGeAlD
Metformin—NDUFAF2—seminal vesicle—prostate cancer	0.000566	0.00474	CbGeAlD
Metformin—NDUFS7—prostate gland—prostate cancer	0.000555	0.00464	CbGeAlD
Metformin—NDUFB6—seminal vesicle—prostate cancer	0.000549	0.0046	CbGeAlD
Metformin—NDUFAF4—seminal vesicle—prostate cancer	0.000549	0.0046	CbGeAlD
Metformin—NDUFB10—seminal vesicle—prostate cancer	0.000541	0.00453	CbGeAlD
Metformin—NDUFB7—seminal vesicle—prostate cancer	0.000537	0.0045	CbGeAlD
Metformin—NDUFA12—seminal vesicle—prostate cancer	0.000537	0.0045	CbGeAlD
Metformin—NDUFAF4—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000536	0.262	CbGdCrCtD
Metformin—NDUFB1—seminal vesicle—prostate cancer	0.000533	0.00447	CbGeAlD
Metformin—NDUFS8—seminal vesicle—prostate cancer	0.000533	0.00447	CbGeAlD
Metformin—NDUFA6—seminal vesicle—prostate cancer	0.000526	0.00441	CbGeAlD
Metformin—NDUFB5—seminal vesicle—prostate cancer	0.000526	0.00441	CbGeAlD
Metformin—ND4L—renal system—prostate cancer	0.000526	0.00441	CbGeAlD
Metformin—ND2—renal system—prostate cancer	0.000526	0.00441	CbGeAlD
Metformin—ND3—renal system—prostate cancer	0.000526	0.00441	CbGeAlD
Metformin—ND5—renal system—prostate cancer	0.000526	0.00441	CbGeAlD
Metformin—NDUFS4—seminal vesicle—prostate cancer	0.000523	0.00438	CbGeAlD
Metformin—NDUFB4—seminal vesicle—prostate cancer	0.000516	0.00432	CbGeAlD
Metformin—NDUFAB1—seminal vesicle—prostate cancer	0.000513	0.00429	CbGeAlD
Metformin—NDUFB9—seminal vesicle—prostate cancer	0.00051	0.00427	CbGeAlD
Metformin—NDUFA8—seminal vesicle—prostate cancer	0.00051	0.00427	CbGeAlD
Metformin—ND4—renal system—prostate cancer	0.000509	0.00426	CbGeAlD
Metformin—PRKAB1—prostate gland—prostate cancer	0.000507	0.00425	CbGeAlD
Metformin—NDUFA4—seminal vesicle—prostate cancer	0.000507	0.00424	CbGeAlD
Metformin—NDUFV1—seminal vesicle—prostate cancer	0.000504	0.00422	CbGeAlD
Metformin—NDUFB11—seminal vesicle—prostate cancer	0.000504	0.00422	CbGeAlD
Metformin—NDUFB8—seminal vesicle—prostate cancer	0.000501	0.00419	CbGeAlD
Metformin—NDUFS5—seminal vesicle—prostate cancer	0.000501	0.00419	CbGeAlD
Metformin—NDUFA2—renal system—prostate cancer	0.000499	0.00418	CbGeAlD
Metformin—NDUFC2—prostate gland—prostate cancer	0.000478	0.004	CbGeAlD
Metformin—NDUFA10—renal system—prostate cancer	0.000476	0.00398	CbGeAlD
Metformin—NDUFB2—renal system—prostate cancer	0.000468	0.00392	CbGeAlD
Metformin—NDUFA12—epithelium—prostate cancer	0.000467	0.00391	CbGeAlD
Metformin—NDUFA7—testis—prostate cancer	0.000465	0.00389	CbGeAlD
Metformin—NDUFAF1—renal system—prostate cancer	0.000464	0.00388	CbGeAlD
Metformin—NDUFC1—urethra—prostate cancer	0.000463	0.00388	CbGeAlD
Metformin—ND6—renal system—prostate cancer	0.00046	0.00385	CbGeAlD
Metformin—NDUFS2—prostate gland—prostate cancer	0.00046	0.00385	CbGeAlD
Metformin—NDUFB3—renal system—prostate cancer	0.000456	0.00382	CbGeAlD
Metformin—NDUFAF1—urethra—prostate cancer	0.000455	0.00381	CbGeAlD
Metformin—NDUFS3—prostate gland—prostate cancer	0.000454	0.0038	CbGeAlD
Metformin—NDUFB3—urethra—prostate cancer	0.000448	0.00375	CbGeAlD
Metformin—NDUFAF2—urethra—prostate cancer	0.000448	0.00375	CbGeAlD
Metformin—NDUFA11—renal system—prostate cancer	0.000446	0.00373	CbGeAlD
Metformin—NDUFA5—renal system—prostate cancer	0.000446	0.00373	CbGeAlD
Metformin—NDUFAB1—epithelium—prostate cancer	0.000446	0.00373	CbGeAlD
Metformin—SLC29A4—testis—prostate cancer	0.000444	0.00372	CbGeAlD
Metformin—NDUFB9—epithelium—prostate cancer	0.000443	0.00371	CbGeAlD
Metformin—NDUFS1—renal system—prostate cancer	0.000439	0.00368	CbGeAlD
Metformin—NDUFA11—urethra—prostate cancer	0.000438	0.00367	CbGeAlD
Metformin—NDUFB10—renal system—prostate cancer	0.000436	0.00365	CbGeAlD
Metformin—NDUFS5—epithelium—prostate cancer	0.000435	0.00364	CbGeAlD
Metformin—NDUFAF4—urethra—prostate cancer	0.000435	0.00364	CbGeAlD
Metformin—NDUFB6—urethra—prostate cancer	0.000435	0.00364	CbGeAlD
Metformin—NDUFAF3—testis—prostate cancer	0.000434	0.00364	CbGeAlD
Metformin—NDUFA12—renal system—prostate cancer	0.000433	0.00362	CbGeAlD
Metformin—NDUFB7—renal system—prostate cancer	0.000433	0.00362	CbGeAlD
Metformin—NDUFB1—renal system—prostate cancer	0.00043	0.0036	CbGeAlD
Metformin—NDUFS8—renal system—prostate cancer	0.00043	0.0036	CbGeAlD
Metformin—PRKAB1—seminal vesicle—prostate cancer	0.000429	0.00359	CbGeAlD
Metformin—NDUFB10—urethra—prostate cancer	0.000428	0.00359	CbGeAlD
Metformin—NDUFB7—urethra—prostate cancer	0.000425	0.00356	CbGeAlD
Metformin—NDUFA12—urethra—prostate cancer	0.000425	0.00356	CbGeAlD
Metformin—NDUFB5—renal system—prostate cancer	0.000424	0.00355	CbGeAlD
Metformin—NDUFA6—renal system—prostate cancer	0.000424	0.00355	CbGeAlD
Metformin—NDUFB1—urethra—prostate cancer	0.000422	0.00354	CbGeAlD
Metformin—NDUFS8—urethra—prostate cancer	0.000422	0.00354	CbGeAlD
Metformin—NDUFS4—renal system—prostate cancer	0.000421	0.00353	CbGeAlD
Metformin—NDUFB5—urethra—prostate cancer	0.000417	0.00349	CbGeAlD
Metformin—NDUFA6—urethra—prostate cancer	0.000417	0.00349	CbGeAlD
Metformin—NDUFB4—renal system—prostate cancer	0.000416	0.00348	CbGeAlD
Metformin—NDUFS4—urethra—prostate cancer	0.000414	0.00347	CbGeAlD
Metformin—NDUFAB1—renal system—prostate cancer	0.000413	0.00346	CbGeAlD
Metformin—NDUFB9—renal system—prostate cancer	0.000411	0.00344	CbGeAlD
Metformin—NDUFA8—renal system—prostate cancer	0.000411	0.00344	CbGeAlD
Metformin—NDUFB4—urethra—prostate cancer	0.000409	0.00342	CbGeAlD
Metformin—NDUFA4—renal system—prostate cancer	0.000408	0.00342	CbGeAlD
Metformin—NDUFAB1—urethra—prostate cancer	0.000406	0.0034	CbGeAlD
Metformin—NDUFB11—renal system—prostate cancer	0.000406	0.0034	CbGeAlD
Metformin—NDUFV1—renal system—prostate cancer	0.000406	0.0034	CbGeAlD
Metformin—NDUFC2—seminal vesicle—prostate cancer	0.000404	0.00339	CbGeAlD
Metformin—NDUFB9—urethra—prostate cancer	0.000403	0.00338	CbGeAlD
Metformin—NDUFA8—urethra—prostate cancer	0.000403	0.00338	CbGeAlD
Metformin—NDUFS5—renal system—prostate cancer	0.000403	0.00338	CbGeAlD
Metformin—NDUFB8—renal system—prostate cancer	0.000403	0.00338	CbGeAlD
Metformin—NDUFA4—urethra—prostate cancer	0.000401	0.00336	CbGeAlD
Metformin—NDUFV1—urethra—prostate cancer	0.000399	0.00334	CbGeAlD
Metformin—NDUFB11—urethra—prostate cancer	0.000399	0.00334	CbGeAlD
Metformin—ND2—bone marrow—prostate cancer	0.000398	0.00333	CbGeAlD
Metformin—ND3—bone marrow—prostate cancer	0.000398	0.00333	CbGeAlD
Metformin—ND5—bone marrow—prostate cancer	0.000398	0.00333	CbGeAlD
Metformin—ND4L—bone marrow—prostate cancer	0.000398	0.00333	CbGeAlD
Metformin—NDUFS5—urethra—prostate cancer	0.000396	0.00332	CbGeAlD
Metformin—NDUFB8—urethra—prostate cancer	0.000396	0.00332	CbGeAlD
Metformin—NDUFA13—testis—prostate cancer	0.000389	0.00326	CbGeAlD
Metformin—NDUFA9—testis—prostate cancer	0.000389	0.00326	CbGeAlD
Metformin—NDUFS2—seminal vesicle—prostate cancer	0.000389	0.00325	CbGeAlD
Metformin—ND4—bone marrow—prostate cancer	0.000385	0.00322	CbGeAlD
Metformin—NDUFS3—seminal vesicle—prostate cancer	0.000384	0.00321	CbGeAlD
Metformin—NDUFS7—renal system—prostate cancer	0.000378	0.00317	CbGeAlD
Metformin—NDUFA2—bone marrow—prostate cancer	0.000377	0.00316	CbGeAlD
Metformin—ND1—prostate gland—prostate cancer	0.000377	0.00316	CbGeAlD
Metformin—NDUFV2—testis—prostate cancer	0.000372	0.00311	CbGeAlD
Metformin—NDUFA4L2—testis—prostate cancer	0.000362	0.00303	CbGeAlD
Metformin—NDUFA10—bone marrow—prostate cancer	0.00036	0.00301	CbGeAlD
Metformin—NDUFC1—bone marrow—prostate cancer	0.000357	0.00299	CbGeAlD
Metformin—NDUFB2—bone marrow—prostate cancer	0.000354	0.00296	CbGeAlD
Metformin—NDUFC2—epithelium—prostate cancer	0.000351	0.00294	CbGeAlD
Metformin—NDUFAF1—bone marrow—prostate cancer	0.000351	0.00294	CbGeAlD
Metformin—ND6—bone marrow—prostate cancer	0.000348	0.00291	CbGeAlD
Metformin—PRKAB1—renal system—prostate cancer	0.000346	0.00289	CbGeAlD
Metformin—NDUFAF2—bone marrow—prostate cancer	0.000345	0.00289	CbGeAlD
Metformin—NDUFB3—bone marrow—prostate cancer	0.000345	0.00289	CbGeAlD
Metformin—ND3—testis—prostate cancer	0.00034	0.00285	CbGeAlD
Metformin—ND5—testis—prostate cancer	0.00034	0.00285	CbGeAlD
Metformin—ND2—testis—prostate cancer	0.00034	0.00285	CbGeAlD
Metformin—ND4L—testis—prostate cancer	0.00034	0.00285	CbGeAlD
Metformin—PRKAB1—urethra—prostate cancer	0.00034	0.00284	CbGeAlD
Metformin—NDUFA7—lymph node—prostate cancer	0.000337	0.00282	CbGeAlD
Metformin—NDUFA5—bone marrow—prostate cancer	0.000337	0.00282	CbGeAlD
Metformin—NDUFAF4—bone marrow—prostate cancer	0.000334	0.0028	CbGeAlD
Metformin—NDUFB6—bone marrow—prostate cancer	0.000334	0.0028	CbGeAlD
Metformin—NDUFS1—bone marrow—prostate cancer	0.000332	0.00278	CbGeAlD
Metformin—NDUFB10—bone marrow—prostate cancer	0.00033	0.00276	CbGeAlD
Metformin—ND4—testis—prostate cancer	0.000329	0.00276	CbGeAlD
Metformin—NDUFA12—bone marrow—prostate cancer	0.000327	0.00274	CbGeAlD
Metformin—NDUFB7—bone marrow—prostate cancer	0.000327	0.00274	CbGeAlD
Metformin—NDUFC2—renal system—prostate cancer	0.000326	0.00273	CbGeAlD
Metformin—NDUFB1—bone marrow—prostate cancer	0.000325	0.00272	CbGeAlD
Metformin—NDUFS8—bone marrow—prostate cancer	0.000325	0.00272	CbGeAlD
Metformin—NDUFA2—testis—prostate cancer	0.000322	0.0027	CbGeAlD
Metformin—NDUFB5—bone marrow—prostate cancer	0.000321	0.00268	CbGeAlD
Metformin—NDUFA6—bone marrow—prostate cancer	0.000321	0.00268	CbGeAlD
Metformin—NDUFC2—urethra—prostate cancer	0.00032	0.00268	CbGeAlD
Metformin—NDUFS4—bone marrow—prostate cancer	0.000319	0.00267	CbGeAlD
Metformin—NDUFB4—bone marrow—prostate cancer	0.000314	0.00263	CbGeAlD
Metformin—NDUFS2—renal system—prostate cancer	0.000313	0.00262	CbGeAlD
Metformin—NDUFAB1—bone marrow—prostate cancer	0.000312	0.00262	CbGeAlD
Metformin—NDUFB9—bone marrow—prostate cancer	0.000311	0.0026	CbGeAlD
Metformin—NDUFA8—bone marrow—prostate cancer	0.000311	0.0026	CbGeAlD
Metformin—NDUFS3—renal system—prostate cancer	0.000309	0.00259	CbGeAlD
Metformin—NDUFA4—bone marrow—prostate cancer	0.000309	0.00258	CbGeAlD
Metformin—NDUFS2—urethra—prostate cancer	0.000308	0.00258	CbGeAlD
Metformin—NDUFA10—testis—prostate cancer	0.000308	0.00258	CbGeAlD
Metformin—NDUFV1—bone marrow—prostate cancer	0.000307	0.00257	CbGeAlD
Metformin—NDUFB11—bone marrow—prostate cancer	0.000307	0.00257	CbGeAlD
Metformin—NDUFB8—bone marrow—prostate cancer	0.000305	0.00255	CbGeAlD
Metformin—NDUFS5—bone marrow—prostate cancer	0.000305	0.00255	CbGeAlD
Metformin—NDUFC1—testis—prostate cancer	0.000305	0.00255	CbGeAlD
Metformin—NDUFS3—urethra—prostate cancer	0.000304	0.00254	CbGeAlD
Metformin—NDUFB2—testis—prostate cancer	0.000302	0.00253	CbGeAlD
Metformin—NDUFAF1—testis—prostate cancer	0.0003	0.00251	CbGeAlD
Metformin—ND6—testis—prostate cancer	0.000297	0.00249	CbGeAlD
Metformin—NDUFAF2—testis—prostate cancer	0.000295	0.00247	CbGeAlD
Metformin—NDUFB3—testis—prostate cancer	0.000295	0.00247	CbGeAlD
Metformin—NDUFA5—testis—prostate cancer	0.000288	0.00241	CbGeAlD
Metformin—NDUFA11—testis—prostate cancer	0.000288	0.00241	CbGeAlD
Metformin—NDUFB6—testis—prostate cancer	0.000286	0.00239	CbGeAlD
Metformin—NDUFAF4—testis—prostate cancer	0.000286	0.00239	CbGeAlD
Metformin—NDUFS7—bone marrow—prostate cancer	0.000286	0.00239	CbGeAlD
Metformin—NDUFS1—testis—prostate cancer	0.000284	0.00238	CbGeAlD
Metformin—NDUFB10—testis—prostate cancer	0.000282	0.00236	CbGeAlD
Metformin—NDUFA12—testis—prostate cancer	0.00028	0.00234	CbGeAlD
Metformin—NDUFB7—testis—prostate cancer	0.00028	0.00234	CbGeAlD
Metformin—NDUFB1—testis—prostate cancer	0.000278	0.00233	CbGeAlD
Metformin—NDUFS8—testis—prostate cancer	0.000278	0.00233	CbGeAlD
Metformin—NDUFB5—testis—prostate cancer	0.000274	0.0023	CbGeAlD
Metformin—NDUFA6—testis—prostate cancer	0.000274	0.0023	CbGeAlD
Metformin—NDUFS4—testis—prostate cancer	0.000272	0.00228	CbGeAlD
Metformin—NDUFV2—lymph node—prostate cancer	0.000269	0.00226	CbGeAlD
Metformin—NDUFB4—testis—prostate cancer	0.000269	0.00225	CbGeAlD
Metformin—NDUFAB1—testis—prostate cancer	0.000267	0.00224	CbGeAlD
Metformin—NDUFA8—testis—prostate cancer	0.000265	0.00222	CbGeAlD
Metformin—NDUFB9—testis—prostate cancer	0.000265	0.00222	CbGeAlD
Metformin—NDUFA4—testis—prostate cancer	0.000264	0.00221	CbGeAlD
Metformin—NDUFB11—testis—prostate cancer	0.000262	0.0022	CbGeAlD
Metformin—NDUFV1—testis—prostate cancer	0.000262	0.0022	CbGeAlD
Metformin—NDUFA4L2—lymph node—prostate cancer	0.000262	0.0022	CbGeAlD
Metformin—PRKAB1—bone marrow—prostate cancer	0.000261	0.00219	CbGeAlD
Metformin—NDUFS5—testis—prostate cancer	0.000261	0.00218	CbGeAlD
Metformin—NDUFB8—testis—prostate cancer	0.000261	0.00218	CbGeAlD
Metformin—ND1—renal system—prostate cancer	0.000257	0.00215	CbGeAlD
Metformin—SLC47A1—prostate gland—prostate cancer	0.000256	0.00214	CbGeAlD
Metformin—ND4L—lymph node—prostate cancer	0.000246	0.00206	CbGeAlD
Metformin—ND3—lymph node—prostate cancer	0.000246	0.00206	CbGeAlD
Metformin—ND2—lymph node—prostate cancer	0.000246	0.00206	CbGeAlD
Metformin—ND5—lymph node—prostate cancer	0.000246	0.00206	CbGeAlD
Metformin—NDUFC2—bone marrow—prostate cancer	0.000246	0.00206	CbGeAlD
Metformin—NDUFS7—testis—prostate cancer	0.000244	0.00205	CbGeAlD
Metformin—ND4—lymph node—prostate cancer	0.000239	0.002	CbGeAlD
Metformin—NDUFS2—bone marrow—prostate cancer	0.000237	0.00198	CbGeAlD
Metformin—NDUFS3—bone marrow—prostate cancer	0.000234	0.00196	CbGeAlD
Metformin—NDUFA2—lymph node—prostate cancer	0.000234	0.00196	CbGeAlD
Metformin—PRKAB1—testis—prostate cancer	0.000223	0.00187	CbGeAlD
Metformin—NDUFA10—lymph node—prostate cancer	0.000223	0.00187	CbGeAlD
Metformin—NDUFC1—lymph node—prostate cancer	0.000221	0.00185	CbGeAlD
Metformin—NDUFB2—lymph node—prostate cancer	0.000219	0.00183	CbGeAlD
Metformin—NDUFAF1—lymph node—prostate cancer	0.000217	0.00182	CbGeAlD
Metformin—SLC47A1—seminal vesicle—prostate cancer	0.000217	0.00181	CbGeAlD
Metformin—ND6—lymph node—prostate cancer	0.000215	0.0018	CbGeAlD
Metformin—NDUFAF2—lymph node—prostate cancer	0.000214	0.00179	CbGeAlD
Metformin—NDUFB3—lymph node—prostate cancer	0.000214	0.00179	CbGeAlD
Metformin—NDUFC2—testis—prostate cancer	0.000211	0.00176	CbGeAlD
Metformin—NDUFA5—lymph node—prostate cancer	0.000209	0.00175	CbGeAlD
Metformin—NDUFA11—lymph node—prostate cancer	0.000209	0.00175	CbGeAlD
Metformin—NDUFAF4—lymph node—prostate cancer	0.000207	0.00174	CbGeAlD
Metformin—NDUFB6—lymph node—prostate cancer	0.000207	0.00174	CbGeAlD
Metformin—SLC22A2—renal system—prostate cancer	0.000206	0.00173	CbGeAlD
Metformin—NDUFS1—lymph node—prostate cancer	0.000206	0.00172	CbGeAlD
Metformin—NDUFB10—lymph node—prostate cancer	0.000204	0.00171	CbGeAlD
Metformin—SLC22A3—prostate gland—prostate cancer	0.000204	0.00171	CbGeAlD
Metformin—NDUFB7—lymph node—prostate cancer	0.000203	0.0017	CbGeAlD
Metformin—NDUFA12—lymph node—prostate cancer	0.000203	0.0017	CbGeAlD
Metformin—NDUFS2—testis—prostate cancer	0.000202	0.0017	CbGeAlD
Metformin—NDUFS8—lymph node—prostate cancer	0.000201	0.00169	CbGeAlD
Metformin—NDUFB1—lymph node—prostate cancer	0.000201	0.00169	CbGeAlD
Metformin—NDUFS3—testis—prostate cancer	0.0002	0.00167	CbGeAlD
Metformin—NDUFB5—lymph node—prostate cancer	0.000199	0.00166	CbGeAlD
Metformin—NDUFA6—lymph node—prostate cancer	0.000199	0.00166	CbGeAlD
Metformin—NDUFS4—lymph node—prostate cancer	0.000197	0.00165	CbGeAlD
Metformin—NDUFB4—lymph node—prostate cancer	0.000195	0.00163	CbGeAlD
Metformin—ND1—bone marrow—prostate cancer	0.000194	0.00163	CbGeAlD
Metformin—NDUFAB1—lymph node—prostate cancer	0.000194	0.00162	CbGeAlD
Metformin—NDUFB9—lymph node—prostate cancer	0.000192	0.00161	CbGeAlD
Metformin—NDUFA8—lymph node—prostate cancer	0.000192	0.00161	CbGeAlD
Metformin—NDUFA4—lymph node—prostate cancer	0.000191	0.0016	CbGeAlD
Metformin—NDUFB11—lymph node—prostate cancer	0.00019	0.00159	CbGeAlD
Metformin—NDUFV1—lymph node—prostate cancer	0.00019	0.00159	CbGeAlD
Metformin—NDUFS5—lymph node—prostate cancer	0.000189	0.00158	CbGeAlD
Metformin—NDUFB8—lymph node—prostate cancer	0.000189	0.00158	CbGeAlD
Metformin—NDUFS7—lymph node—prostate cancer	0.000177	0.00148	CbGeAlD
Metformin—SLC47A1—renal system—prostate cancer	0.000175	0.00146	CbGeAlD
Metformin—SLC22A3—seminal vesicle—prostate cancer	0.000173	0.00145	CbGeAlD
Metformin—SLC47A1—urethra—prostate cancer	0.000171	0.00144	CbGeAlD
Metformin—ND1—testis—prostate cancer	0.000166	0.00139	CbGeAlD
Metformin—PRKAB1—lymph node—prostate cancer	0.000162	0.00136	CbGeAlD
Metformin—NDUFC2—lymph node—prostate cancer	0.000153	0.00128	CbGeAlD
Metformin—NDUFS2—lymph node—prostate cancer	0.000147	0.00123	CbGeAlD
Metformin—SLC22A1—renal system—prostate cancer	0.000146	0.00122	CbGeAlD
Metformin—NDUFS3—lymph node—prostate cancer	0.000145	0.00121	CbGeAlD
Metformin—SLC22A3—renal system—prostate cancer	0.000139	0.00117	CbGeAlD
Metformin—SLC22A3—urethra—prostate cancer	0.000137	0.00115	CbGeAlD
Metformin—ND1—lymph node—prostate cancer	0.00012	0.00101	CbGeAlD
Metformin—SLC47A1—testis—prostate cancer	0.000113	0.000945	CbGeAlD
Metformin—SLC22A3—testis—prostate cancer	9e-05	0.000753	CbGeAlD
Metformin—SLC47A1—lymph node—prostate cancer	8.18e-05	0.000685	CbGeAlD
Metformin—SLC22A3—lymph node—prostate cancer	6.52e-05	0.000546	CbGeAlD
Metformin—Hypertension—Capecitabine—prostate cancer	4.92e-05	0.000371	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—prostate cancer	4.9e-05	0.000369	CcSEcCtD
Metformin—Myalgia—Capecitabine—prostate cancer	4.85e-05	0.000366	CcSEcCtD
Metformin—Chest pain—Capecitabine—prostate cancer	4.85e-05	0.000366	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.82e-05	0.000363	CcSEcCtD
Metformin—Hepatobiliary disease—Epirubicin—prostate cancer	4.81e-05	0.000362	CcSEcCtD
Metformin—Oedema—Docetaxel—prostate cancer	4.81e-05	0.000362	CcSEcCtD
Metformin—Discomfort—Capecitabine—prostate cancer	4.8e-05	0.000361	CcSEcCtD
Metformin—Vision blurred—Prednisone—prostate cancer	4.79e-05	0.000361	CcSEcCtD
Metformin—Infection—Docetaxel—prostate cancer	4.77e-05	0.00036	CcSEcCtD
Metformin—Feeling abnormal—Etoposide—prostate cancer	4.77e-05	0.000359	CcSEcCtD
Metformin—Diarrhoea—Mitoxantrone—prostate cancer	4.76e-05	0.000358	CcSEcCtD
Metformin—Vomiting—Estradiol—prostate cancer	4.74e-05	0.000357	CcSEcCtD
Metformin—Gastrointestinal pain—Etoposide—prostate cancer	4.73e-05	0.000356	CcSEcCtD
Metformin—Shock—Docetaxel—prostate cancer	4.73e-05	0.000356	CcSEcCtD
Metformin—Nervous system disorder—Docetaxel—prostate cancer	4.71e-05	0.000355	CcSEcCtD
Metformin—Ill-defined disorder—Prednisone—prostate cancer	4.71e-05	0.000355	CcSEcCtD
Metformin—Thrombocytopenia—Docetaxel—prostate cancer	4.71e-05	0.000355	CcSEcCtD
Metformin—Rash—Estradiol—prostate cancer	4.7e-05	0.000355	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—prostate cancer	4.7e-05	0.000354	CcSEcCtD
Metformin—Infestation—Doxorubicin—prostate cancer	4.7e-05	0.000354	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—prostate cancer	4.7e-05	0.000354	CcSEcCtD
Metformin—Dermatitis—Estradiol—prostate cancer	4.7e-05	0.000354	CcSEcCtD
Metformin—Headache—Estradiol—prostate cancer	4.67e-05	0.000352	CcSEcCtD
Metformin—Skin disorder—Docetaxel—prostate cancer	4.67e-05	0.000352	CcSEcCtD
Metformin—Oedema—Capecitabine—prostate cancer	4.65e-05	0.000351	CcSEcCtD
Metformin—Bradycardia—Epirubicin—prostate cancer	4.64e-05	0.00035	CcSEcCtD
Metformin—Infection—Capecitabine—prostate cancer	4.62e-05	0.000348	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—prostate cancer	4.61e-05	0.000347	CcSEcCtD
Metformin—Urticaria—Etoposide—prostate cancer	4.59e-05	0.000346	CcSEcCtD
Metformin—Anorexia—Docetaxel—prostate cancer	4.58e-05	0.000345	CcSEcCtD
Metformin—Malaise—Prednisone—prostate cancer	4.58e-05	0.000345	CcSEcCtD
Metformin—Shock—Capecitabine—prostate cancer	4.58e-05	0.000345	CcSEcCtD
Metformin—Rhinitis—Epirubicin—prostate cancer	4.57e-05	0.000345	CcSEcCtD
Metformin—Abdominal pain—Etoposide—prostate cancer	4.57e-05	0.000344	CcSEcCtD
Metformin—Nervous system disorder—Capecitabine—prostate cancer	4.56e-05	0.000344	CcSEcCtD
Metformin—Hepatitis—Epirubicin—prostate cancer	4.56e-05	0.000344	CcSEcCtD
Metformin—Thrombocytopenia—Capecitabine—prostate cancer	4.56e-05	0.000343	CcSEcCtD
Metformin—Syncope—Prednisone—prostate cancer	4.55e-05	0.000343	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—prostate cancer	4.54e-05	0.000342	CcSEcCtD
Metformin—Skin disorder—Capecitabine—prostate cancer	4.52e-05	0.000341	CcSEcCtD
Metformin—Hyperhidrosis—Capecitabine—prostate cancer	4.5e-05	0.000339	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—prostate cancer	4.49e-05	0.000339	CcSEcCtD
Metformin—Hypotension—Docetaxel—prostate cancer	4.49e-05	0.000338	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—prostate cancer	4.48e-05	0.000338	CcSEcCtD
Metformin—Loss of consciousness—Prednisone—prostate cancer	4.46e-05	0.000336	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—prostate cancer	4.45e-05	0.000335	CcSEcCtD
Metformin—Anorexia—Capecitabine—prostate cancer	4.44e-05	0.000334	CcSEcCtD
Metformin—Nausea—Estradiol—prostate cancer	4.43e-05	0.000334	CcSEcCtD
Metformin—Vomiting—Mitoxantrone—prostate cancer	4.42e-05	0.000333	CcSEcCtD
Metformin—Hypertension—Prednisone—prostate cancer	4.38e-05	0.00033	CcSEcCtD
Metformin—Rash—Mitoxantrone—prostate cancer	4.38e-05	0.00033	CcSEcCtD
Metformin—Dermatitis—Mitoxantrone—prostate cancer	4.38e-05	0.00033	CcSEcCtD
Metformin—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.38e-05	0.00033	CcSEcCtD
Metformin—Headache—Mitoxantrone—prostate cancer	4.36e-05	0.000328	CcSEcCtD
Metformin—Hypotension—Capecitabine—prostate cancer	4.35e-05	0.000328	CcSEcCtD
Metformin—Myalgia—Prednisone—prostate cancer	4.32e-05	0.000326	CcSEcCtD
Metformin—Paraesthesia—Docetaxel—prostate cancer	4.32e-05	0.000325	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—prostate cancer	4.3e-05	0.000324	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.29e-05	0.000324	CcSEcCtD
Metformin—Dyspnoea—Docetaxel—prostate cancer	4.28e-05	0.000323	CcSEcCtD
Metformin—Somnolence—Docetaxel—prostate cancer	4.27e-05	0.000322	CcSEcCtD
Metformin—Discomfort—Prednisone—prostate cancer	4.27e-05	0.000322	CcSEcCtD
Metformin—Eye disorder—Epirubicin—prostate cancer	4.26e-05	0.000321	CcSEcCtD
Metformin—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.24e-05	0.000319	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—prostate cancer	4.23e-05	0.000319	CcSEcCtD
Metformin—Flushing—Epirubicin—prostate cancer	4.23e-05	0.000319	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—prostate cancer	4.23e-05	0.000319	CcSEcCtD
Metformin—Dyspepsia—Docetaxel—prostate cancer	4.23e-05	0.000319	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—prostate cancer	4.22e-05	0.000318	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—prostate cancer	4.2e-05	0.000317	CcSEcCtD
Metformin—Paraesthesia—Capecitabine—prostate cancer	4.18e-05	0.000315	CcSEcCtD
Metformin—Decreased appetite—Docetaxel—prostate cancer	4.18e-05	0.000315	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—prostate cancer	4.16e-05	0.000313	CcSEcCtD
Metformin—Gastrointestinal disorder—Docetaxel—prostate cancer	4.15e-05	0.000313	CcSEcCtD
Metformin—Asthenia—Etoposide—prostate cancer	4.15e-05	0.000313	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—prostate cancer	4.15e-05	0.000313	CcSEcCtD
Metformin—Dyspnoea—Capecitabine—prostate cancer	4.15e-05	0.000313	CcSEcCtD
Metformin—Oedema—Prednisone—prostate cancer	4.14e-05	0.000312	CcSEcCtD
Metformin—Fatigue—Docetaxel—prostate cancer	4.14e-05	0.000312	CcSEcCtD
Metformin—Angiopathy—Epirubicin—prostate cancer	4.14e-05	0.000312	CcSEcCtD
Metformin—Nausea—Mitoxantrone—prostate cancer	4.13e-05	0.000311	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—prostate cancer	4.12e-05	0.000311	CcSEcCtD
Metformin—Infection—Prednisone—prostate cancer	4.12e-05	0.00031	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—prostate cancer	4.11e-05	0.00031	CcSEcCtD
Metformin—Constipation—Docetaxel—prostate cancer	4.11e-05	0.00031	CcSEcCtD
Metformin—Dyspepsia—Capecitabine—prostate cancer	4.1e-05	0.000309	CcSEcCtD
Metformin—Chills—Epirubicin—prostate cancer	4.09e-05	0.000308	CcSEcCtD
Metformin—Pruritus—Etoposide—prostate cancer	4.09e-05	0.000308	CcSEcCtD
Metformin—Shock—Prednisone—prostate cancer	4.08e-05	0.000307	CcSEcCtD
Metformin—Nervous system disorder—Prednisone—prostate cancer	4.06e-05	0.000306	CcSEcCtD
Metformin—Decreased appetite—Capecitabine—prostate cancer	4.04e-05	0.000305	CcSEcCtD
Metformin—Skin disorder—Prednisone—prostate cancer	4.03e-05	0.000303	CcSEcCtD
Metformin—Gastrointestinal disorder—Capecitabine—prostate cancer	4.02e-05	0.000303	CcSEcCtD
Metformin—Fatigue—Capecitabine—prostate cancer	4.01e-05	0.000302	CcSEcCtD
Metformin—Hyperhidrosis—Prednisone—prostate cancer	4.01e-05	0.000302	CcSEcCtD
Metformin—Constipation—Capecitabine—prostate cancer	3.98e-05	0.0003	CcSEcCtD
Metformin—Malnutrition—Epirubicin—prostate cancer	3.97e-05	0.000299	CcSEcCtD
Metformin—Erythema—Epirubicin—prostate cancer	3.97e-05	0.000299	CcSEcCtD
Metformin—Feeling abnormal—Docetaxel—prostate cancer	3.96e-05	0.000298	CcSEcCtD
Metformin—Diarrhoea—Etoposide—prostate cancer	3.96e-05	0.000298	CcSEcCtD
Metformin—Anorexia—Prednisone—prostate cancer	3.95e-05	0.000298	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—prostate cancer	3.95e-05	0.000297	CcSEcCtD
Metformin—Gastrointestinal pain—Docetaxel—prostate cancer	3.93e-05	0.000296	CcSEcCtD
Metformin—Flushing—Doxorubicin—prostate cancer	3.92e-05	0.000295	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—prostate cancer	3.92e-05	0.000295	CcSEcCtD
Metformin—Flatulence—Epirubicin—prostate cancer	3.91e-05	0.000295	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—prostate cancer	3.89e-05	0.000293	CcSEcCtD
Metformin—Feeling abnormal—Capecitabine—prostate cancer	3.83e-05	0.000289	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—prostate cancer	3.83e-05	0.000289	CcSEcCtD
Metformin—Dizziness—Etoposide—prostate cancer	3.82e-05	0.000288	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—prostate cancer	3.82e-05	0.000288	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—prostate cancer	3.81e-05	0.000287	CcSEcCtD
Metformin—Gastrointestinal pain—Capecitabine—prostate cancer	3.8e-05	0.000287	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—prostate cancer	3.8e-05	0.000287	CcSEcCtD
Metformin—Abdominal pain—Docetaxel—prostate cancer	3.8e-05	0.000286	CcSEcCtD
Metformin—Chills—Doxorubicin—prostate cancer	3.79e-05	0.000285	CcSEcCtD
Metformin—Musculoskeletal discomfort—Prednisone—prostate cancer	3.78e-05	0.000285	CcSEcCtD
Metformin—Vision blurred—Epirubicin—prostate cancer	3.74e-05	0.000282	CcSEcCtD
Metformin—Paraesthesia—Prednisone—prostate cancer	3.72e-05	0.00028	CcSEcCtD
Metformin—Urticaria—Capecitabine—prostate cancer	3.7e-05	0.000279	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—prostate cancer	3.69e-05	0.000278	CcSEcCtD
Metformin—Abdominal pain—Capecitabine—prostate cancer	3.68e-05	0.000277	CcSEcCtD
Metformin—Vomiting—Etoposide—prostate cancer	3.68e-05	0.000277	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—prostate cancer	3.67e-05	0.000277	CcSEcCtD
Metformin—Erythema—Doxorubicin—prostate cancer	3.67e-05	0.000277	CcSEcCtD
Metformin—Dyspepsia—Prednisone—prostate cancer	3.65e-05	0.000275	CcSEcCtD
Metformin—Rash—Etoposide—prostate cancer	3.65e-05	0.000275	CcSEcCtD
Metformin—Dermatitis—Etoposide—prostate cancer	3.64e-05	0.000275	CcSEcCtD
Metformin—Headache—Etoposide—prostate cancer	3.62e-05	0.000273	CcSEcCtD
Metformin—Flatulence—Doxorubicin—prostate cancer	3.62e-05	0.000273	CcSEcCtD
Metformin—Decreased appetite—Prednisone—prostate cancer	3.6e-05	0.000271	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—prostate cancer	3.6e-05	0.000271	CcSEcCtD
Metformin—Malaise—Epirubicin—prostate cancer	3.58e-05	0.00027	CcSEcCtD
Metformin—Fatigue—Prednisone—prostate cancer	3.57e-05	0.000269	CcSEcCtD
Metformin—Syncope—Epirubicin—prostate cancer	3.56e-05	0.000268	CcSEcCtD
Metformin—Constipation—Prednisone—prostate cancer	3.54e-05	0.000267	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—prostate cancer	3.53e-05	0.000266	CcSEcCtD
Metformin—Palpitations—Epirubicin—prostate cancer	3.51e-05	0.000264	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—prostate cancer	3.49e-05	0.000263	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—prostate cancer	3.46e-05	0.000261	CcSEcCtD
Metformin—Asthenia—Docetaxel—prostate cancer	3.45e-05	0.00026	CcSEcCtD
Metformin—Nausea—Etoposide—prostate cancer	3.43e-05	0.000259	CcSEcCtD
Metformin—Hypertension—Epirubicin—prostate cancer	3.43e-05	0.000258	CcSEcCtD
Metformin—Feeling abnormal—Prednisone—prostate cancer	3.42e-05	0.000257	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—prostate cancer	3.41e-05	0.000257	CcSEcCtD
Metformin—Pruritus—Docetaxel—prostate cancer	3.4e-05	0.000256	CcSEcCtD
Metformin—Gastrointestinal pain—Prednisone—prostate cancer	3.39e-05	0.000255	CcSEcCtD
Metformin—Chest pain—Epirubicin—prostate cancer	3.38e-05	0.000255	CcSEcCtD
Metformin—Myalgia—Epirubicin—prostate cancer	3.38e-05	0.000255	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.36e-05	0.000253	CcSEcCtD
Metformin—Discomfort—Epirubicin—prostate cancer	3.34e-05	0.000252	CcSEcCtD
Metformin—Asthenia—Capecitabine—prostate cancer	3.34e-05	0.000252	CcSEcCtD
Metformin—Malaise—Doxorubicin—prostate cancer	3.31e-05	0.00025	CcSEcCtD
Metformin—Syncope—Doxorubicin—prostate cancer	3.3e-05	0.000248	CcSEcCtD
Metformin—Urticaria—Prednisone—prostate cancer	3.29e-05	0.000248	CcSEcCtD
Metformin—Pruritus—Capecitabine—prostate cancer	3.29e-05	0.000248	CcSEcCtD
Metformin—Diarrhoea—Docetaxel—prostate cancer	3.29e-05	0.000248	CcSEcCtD
Metformin—Abdominal pain—Prednisone—prostate cancer	3.28e-05	0.000247	CcSEcCtD
Metformin—Palpitations—Doxorubicin—prostate cancer	3.25e-05	0.000245	CcSEcCtD
Metformin—Oedema—Epirubicin—prostate cancer	3.24e-05	0.000244	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—prostate cancer	3.23e-05	0.000243	CcSEcCtD
Metformin—Infection—Epirubicin—prostate cancer	3.22e-05	0.000243	CcSEcCtD
Metformin—Shock—Epirubicin—prostate cancer	3.19e-05	0.00024	CcSEcCtD
Metformin—Diarrhoea—Capecitabine—prostate cancer	3.18e-05	0.00024	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—prostate cancer	3.18e-05	0.00024	CcSEcCtD
Metformin—Dizziness—Docetaxel—prostate cancer	3.18e-05	0.000239	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—prostate cancer	3.17e-05	0.000239	CcSEcCtD
Metformin—Hypertension—Doxorubicin—prostate cancer	3.17e-05	0.000239	CcSEcCtD
Metformin—Skin disorder—Epirubicin—prostate cancer	3.15e-05	0.000237	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—prostate cancer	3.13e-05	0.000236	CcSEcCtD
Metformin—Myalgia—Doxorubicin—prostate cancer	3.13e-05	0.000236	CcSEcCtD
Metformin—Chest pain—Doxorubicin—prostate cancer	3.13e-05	0.000236	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.11e-05	0.000234	CcSEcCtD
Metformin—Discomfort—Doxorubicin—prostate cancer	3.09e-05	0.000233	CcSEcCtD
Metformin—Anorexia—Epirubicin—prostate cancer	3.09e-05	0.000233	CcSEcCtD
Metformin—Dizziness—Capecitabine—prostate cancer	3.08e-05	0.000232	CcSEcCtD
Metformin—Vomiting—Docetaxel—prostate cancer	3.06e-05	0.00023	CcSEcCtD
Metformin—Rash—Docetaxel—prostate cancer	3.03e-05	0.000228	CcSEcCtD
Metformin—Hypotension—Epirubicin—prostate cancer	3.03e-05	0.000228	CcSEcCtD
Metformin—Dermatitis—Docetaxel—prostate cancer	3.03e-05	0.000228	CcSEcCtD
Metformin—Headache—Docetaxel—prostate cancer	3.01e-05	0.000227	CcSEcCtD
Metformin—Oedema—Doxorubicin—prostate cancer	3e-05	0.000226	CcSEcCtD
Metformin—Infection—Doxorubicin—prostate cancer	2.98e-05	0.000225	CcSEcCtD
Metformin—Asthenia—Prednisone—prostate cancer	2.97e-05	0.000224	CcSEcCtD
Metformin—Vomiting—Capecitabine—prostate cancer	2.96e-05	0.000223	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.95e-05	0.000223	CcSEcCtD
Metformin—Shock—Doxorubicin—prostate cancer	2.95e-05	0.000222	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—prostate cancer	2.94e-05	0.000222	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—prostate cancer	2.94e-05	0.000221	CcSEcCtD
Metformin—Rash—Capecitabine—prostate cancer	2.93e-05	0.000221	CcSEcCtD
Metformin—Pruritus—Prednisone—prostate cancer	2.93e-05	0.000221	CcSEcCtD
Metformin—Dermatitis—Capecitabine—prostate cancer	2.93e-05	0.000221	CcSEcCtD
Metformin—Headache—Capecitabine—prostate cancer	2.91e-05	0.00022	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—prostate cancer	2.91e-05	0.00022	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—prostate cancer	2.91e-05	0.000219	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—prostate cancer	2.9e-05	0.000218	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—prostate cancer	2.89e-05	0.000218	CcSEcCtD
Metformin—Somnolence—Epirubicin—prostate cancer	2.88e-05	0.000217	CcSEcCtD
Metformin—Anorexia—Doxorubicin—prostate cancer	2.86e-05	0.000215	CcSEcCtD
Metformin—Nausea—Docetaxel—prostate cancer	2.85e-05	0.000215	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—prostate cancer	2.85e-05	0.000215	CcSEcCtD
Metformin—Diarrhoea—Prednisone—prostate cancer	2.84e-05	0.000214	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—prostate cancer	2.82e-05	0.000212	CcSEcCtD
Metformin—Hypotension—Doxorubicin—prostate cancer	2.8e-05	0.000211	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—prostate cancer	2.8e-05	0.000211	CcSEcCtD
Metformin—Fatigue—Epirubicin—prostate cancer	2.79e-05	0.000211	CcSEcCtD
Metformin—Constipation—Epirubicin—prostate cancer	2.77e-05	0.000209	CcSEcCtD
Metformin—Nausea—Capecitabine—prostate cancer	2.76e-05	0.000208	CcSEcCtD
Metformin—Dizziness—Prednisone—prostate cancer	2.74e-05	0.000207	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.73e-05	0.000206	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—prostate cancer	2.69e-05	0.000203	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—prostate cancer	2.67e-05	0.000201	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—prostate cancer	2.67e-05	0.000201	CcSEcCtD
Metformin—Somnolence—Doxorubicin—prostate cancer	2.67e-05	0.000201	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—prostate cancer	2.65e-05	0.0002	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—prostate cancer	2.64e-05	0.000199	CcSEcCtD
Metformin—Vomiting—Prednisone—prostate cancer	2.64e-05	0.000199	CcSEcCtD
Metformin—Rash—Prednisone—prostate cancer	2.61e-05	0.000197	CcSEcCtD
Metformin—Dermatitis—Prednisone—prostate cancer	2.61e-05	0.000197	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—prostate cancer	2.61e-05	0.000196	CcSEcCtD
Metformin—Headache—Prednisone—prostate cancer	2.6e-05	0.000196	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.59e-05	0.000195	CcSEcCtD
Metformin—Fatigue—Doxorubicin—prostate cancer	2.59e-05	0.000195	CcSEcCtD
Metformin—Urticaria—Epirubicin—prostate cancer	2.58e-05	0.000194	CcSEcCtD
Metformin—Constipation—Doxorubicin—prostate cancer	2.56e-05	0.000193	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—prostate cancer	2.56e-05	0.000193	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—prostate cancer	2.47e-05	0.000186	CcSEcCtD
Metformin—Nausea—Prednisone—prostate cancer	2.46e-05	0.000186	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—prostate cancer	2.45e-05	0.000185	CcSEcCtD
Metformin—Urticaria—Doxorubicin—prostate cancer	2.38e-05	0.00018	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—prostate cancer	2.37e-05	0.000179	CcSEcCtD
Metformin—Asthenia—Epirubicin—prostate cancer	2.33e-05	0.000175	CcSEcCtD
Metformin—Pruritus—Epirubicin—prostate cancer	2.29e-05	0.000173	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—prostate cancer	2.22e-05	0.000167	CcSEcCtD
Metformin—Asthenia—Doxorubicin—prostate cancer	2.15e-05	0.000162	CcSEcCtD
Metformin—Dizziness—Epirubicin—prostate cancer	2.14e-05	0.000162	CcSEcCtD
Metformin—Pruritus—Doxorubicin—prostate cancer	2.12e-05	0.00016	CcSEcCtD
Metformin—Vomiting—Epirubicin—prostate cancer	2.06e-05	0.000155	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—prostate cancer	2.05e-05	0.000155	CcSEcCtD
Metformin—Rash—Epirubicin—prostate cancer	2.04e-05	0.000154	CcSEcCtD
Metformin—Dermatitis—Epirubicin—prostate cancer	2.04e-05	0.000154	CcSEcCtD
Metformin—Headache—Epirubicin—prostate cancer	2.03e-05	0.000153	CcSEcCtD
Metformin—Dizziness—Doxorubicin—prostate cancer	1.98e-05	0.000149	CcSEcCtD
Metformin—Nausea—Epirubicin—prostate cancer	1.93e-05	0.000145	CcSEcCtD
Metformin—Vomiting—Doxorubicin—prostate cancer	1.91e-05	0.000144	CcSEcCtD
Metformin—Rash—Doxorubicin—prostate cancer	1.89e-05	0.000143	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—prostate cancer	1.89e-05	0.000142	CcSEcCtD
Metformin—Headache—Doxorubicin—prostate cancer	1.88e-05	0.000142	CcSEcCtD
Metformin—Nausea—Doxorubicin—prostate cancer	1.78e-05	0.000134	CcSEcCtD
Metformin—SLC22A1—Neuronal System—MDM2—prostate cancer	2.59e-06	1.82e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC5A5—prostate cancer	2.57e-06	1.81e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CAV1—prostate cancer	2.57e-06	1.81e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—prostate cancer	2.55e-06	1.8e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—prostate cancer	2.55e-06	1.8e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—prostate cancer	2.55e-06	1.8e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—prostate cancer	2.55e-06	1.8e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—prostate cancer	2.54e-06	1.79e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA2—prostate cancer	2.54e-06	1.78e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC22A3—prostate cancer	2.53e-06	1.78e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HSD3B1—prostate cancer	2.53e-06	1.78e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—NOS3—prostate cancer	2.52e-06	1.77e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2E1—prostate cancer	2.51e-06	1.77e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCG5—prostate cancer	2.51e-06	1.76e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SULT1A1—prostate cancer	2.51e-06	1.76e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NQO1—prostate cancer	2.49e-06	1.75e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ESR1—prostate cancer	2.48e-06	1.74e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TH—prostate cancer	2.45e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA1—prostate cancer	2.45e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TBXAS1—prostate cancer	2.43e-06	1.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA4—prostate cancer	2.43e-06	1.71e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP3A4—prostate cancer	2.42e-06	1.71e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BAD—prostate cancer	2.42e-06	1.7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NAT2—prostate cancer	2.42e-06	1.7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTO1—prostate cancer	2.42e-06	1.7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HSD3B2—prostate cancer	2.42e-06	1.7e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1B1—prostate cancer	2.38e-06	1.68e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—prostate cancer	2.37e-06	1.67e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA2—prostate cancer	2.36e-06	1.66e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—prostate cancer	2.34e-06	1.65e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—prostate cancer	2.34e-06	1.65e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SULT1A1—prostate cancer	2.34e-06	1.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCG5—prostate cancer	2.34e-06	1.64e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—prostate cancer	2.33e-06	1.64e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2C18—prostate cancer	2.32e-06	1.63e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLCB2—prostate cancer	2.32e-06	1.63e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LRP2—prostate cancer	2.32e-06	1.63e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IRS1—prostate cancer	2.32e-06	1.63e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGF—prostate cancer	2.32e-06	1.63e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GGT1—prostate cancer	2.31e-06	1.62e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—prostate cancer	2.31e-06	1.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA1—prostate cancer	2.28e-06	1.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—P4HB—prostate cancer	2.28e-06	1.6e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NCOA1—prostate cancer	2.27e-06	1.6e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HSD3B2—prostate cancer	2.26e-06	1.59e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTO1—prostate cancer	2.26e-06	1.59e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NAT2—prostate cancer	2.26e-06	1.59e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—GSK3B—prostate cancer	2.25e-06	1.58e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP19A1—prostate cancer	2.24e-06	1.58e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—INS—prostate cancer	2.22e-06	1.56e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC22A1—prostate cancer	2.21e-06	1.56e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.21e-06	1.56e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—prostate cancer	2.2e-06	1.55e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—prostate cancer	2.2e-06	1.55e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—prostate cancer	2.2e-06	1.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CREBBP—prostate cancer	2.17e-06	1.53e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—RXRA—prostate cancer	2.16e-06	1.52e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLCB2—prostate cancer	2.16e-06	1.52e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2C18—prostate cancer	2.16e-06	1.52e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LRP2—prostate cancer	2.16e-06	1.52e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SULT2A1—prostate cancer	2.16e-06	1.52e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1—prostate cancer	2.15e-06	1.51e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MED12—prostate cancer	2.12e-06	1.49e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—P4HB—prostate cancer	2.12e-06	1.49e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—prostate cancer	2.12e-06	1.49e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GNG5—prostate cancer	2.11e-06	1.48e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—COMT—prostate cancer	2.08e-06	1.47e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAP2K1—prostate cancer	2.07e-06	1.46e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—prostate cancer	2.07e-06	1.46e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—prostate cancer	2.07e-06	1.46e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.06e-06	1.45e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—prostate cancer	2.06e-06	1.45e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ITPR1—prostate cancer	2.04e-06	1.44e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SERPINE1—prostate cancer	2.04e-06	1.43e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOA3—prostate cancer	2.03e-06	1.43e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—prostate cancer	2.01e-06	1.41e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SULT2A1—prostate cancer	2.01e-06	1.41e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MED12—prostate cancer	1.98e-06	1.39e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGF2—prostate cancer	1.97e-06	1.39e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GNG5—prostate cancer	1.96e-06	1.38e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOS3—prostate cancer	1.95e-06	1.37e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HPGDS—prostate cancer	1.93e-06	1.36e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMS—prostate cancer	1.93e-06	1.36e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2C19—prostate cancer	1.92e-06	1.35e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—EP300—prostate cancer	1.92e-06	1.35e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—prostate cancer	1.91e-06	1.34e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JAK2—prostate cancer	1.89e-06	1.33e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA3—prostate cancer	1.89e-06	1.33e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTT1—prostate cancer	1.88e-06	1.32e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ACHE—prostate cancer	1.88e-06	1.32e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—LPL—prostate cancer	1.87e-06	1.32e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2A6—prostate cancer	1.85e-06	1.3e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—prostate cancer	1.85e-06	1.3e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—prostate cancer	1.82e-06	1.28e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1A1—prostate cancer	1.81e-06	1.27e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKR1C3—prostate cancer	1.8e-06	1.27e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HPGDS—prostate cancer	1.8e-06	1.27e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—prostate cancer	1.8e-06	1.27e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—prostate cancer	1.8e-06	1.27e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—prostate cancer	1.8e-06	1.27e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—prostate cancer	1.8e-06	1.26e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PRKACB—prostate cancer	1.79e-06	1.26e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2C19—prostate cancer	1.79e-06	1.26e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ERCC2—prostate cancer	1.79e-06	1.26e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP17A1—prostate cancer	1.78e-06	1.25e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.76e-06	1.24e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ACHE—prostate cancer	1.75e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTT1—prostate cancer	1.75e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2A6—prostate cancer	1.73e-06	1.22e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—prostate cancer	1.73e-06	1.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOA2—prostate cancer	1.69e-06	1.19e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—prostate cancer	1.69e-06	1.19e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1B—prostate cancer	1.69e-06	1.19e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—prostate cancer	1.68e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKR1C3—prostate cancer	1.68e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PRKACB—prostate cancer	1.67e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP17A1—prostate cancer	1.66e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARA—prostate cancer	1.65e-06	1.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—prostate cancer	1.65e-06	1.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—prostate cancer	1.65e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.64e-06	1.15e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC5A5—prostate cancer	1.61e-06	1.14e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—prostate cancer	1.61e-06	1.13e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—prostate cancer	1.59e-06	1.12e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA2—prostate cancer	1.58e-06	1.11e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2E1—prostate cancer	1.58e-06	1.11e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—prostate cancer	1.56e-06	1.1e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NQO1—prostate cancer	1.56e-06	1.1e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—prostate cancer	1.56e-06	1.09e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAV1—prostate cancer	1.55e-06	1.09e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—prostate cancer	1.55e-06	1.09e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TH—prostate cancer	1.54e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP3A4—prostate cancer	1.52e-06	1.07e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A5—prostate cancer	1.5e-06	1.06e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1B1—prostate cancer	1.49e-06	1.05e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EP300—prostate cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2E1—prostate cancer	1.47e-06	1.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NQO1—prostate cancer	1.45e-06	1.02e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GGT1—prostate cancer	1.45e-06	1.02e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—prostate cancer	1.44e-06	1.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TH—prostate cancer	1.43e-06	1.01e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOA1—prostate cancer	1.43e-06	1e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—prostate cancer	1.42e-06	9.98e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP3A4—prostate cancer	1.42e-06	9.97e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—prostate cancer	1.41e-06	9.95e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP19A1—prostate cancer	1.41e-06	9.89e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—prostate cancer	1.4e-06	9.86e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1B1—prostate cancer	1.39e-06	9.8e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—prostate cancer	1.39e-06	9.76e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—RXRA—prostate cancer	1.36e-06	9.54e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GGT1—prostate cancer	1.35e-06	9.49e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—INS—prostate cancer	1.34e-06	9.42e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA1—prostate cancer	1.33e-06	9.35e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CREBBP—prostate cancer	1.31e-06	9.23e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP19A1—prostate cancer	1.31e-06	9.22e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—COMT—prostate cancer	1.31e-06	9.19e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—prostate cancer	1.3e-06	9.15e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—prostate cancer	1.29e-06	9.07e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFB1—prostate cancer	1.29e-06	9.05e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ITPR1—prostate cancer	1.28e-06	9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—RXRA—prostate cancer	1.26e-06	8.89e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—prostate cancer	1.26e-06	8.87e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—prostate cancer	1.24e-06	8.75e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—COMT—prostate cancer	1.22e-06	8.57e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—prostate cancer	1.21e-06	8.53e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMS—prostate cancer	1.21e-06	8.5e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—prostate cancer	1.2e-06	8.41e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ITPR1—prostate cancer	1.19e-06	8.39e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—prostate cancer	1.19e-06	8.38e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NOS3—prostate cancer	1.17e-06	8.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LPL—prostate cancer	1.17e-06	8.25e-06	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—prostate cancer	1.16e-06	8.15e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1A1—prostate cancer	1.13e-06	7.97e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMS—prostate cancer	1.13e-06	7.93e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ERCC2—prostate cancer	1.12e-06	7.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—prostate cancer	1.11e-06	7.84e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—prostate cancer	1.09e-06	7.7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LPL—prostate cancer	1.09e-06	7.69e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—prostate cancer	1.08e-06	7.63e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—prostate cancer	1.07e-06	7.56e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—prostate cancer	1.06e-06	7.45e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—prostate cancer	1.06e-06	7.43e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1A1—prostate cancer	1.06e-06	7.43e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ERCC2—prostate cancer	1.05e-06	7.37e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARA—prostate cancer	1.04e-06	7.29e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—prostate cancer	9.84e-07	6.92e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAV1—prostate cancer	9.74e-07	6.85e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—prostate cancer	9.69e-07	6.82e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARA—prostate cancer	9.66e-07	6.79e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—prostate cancer	9.37e-07	6.59e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAV1—prostate cancer	9.08e-07	6.39e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—prostate cancer	8.94e-07	6.29e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—EP300—prostate cancer	8.93e-07	6.28e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—prostate cancer	8.87e-07	6.24e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—INS—prostate cancer	8.4e-07	5.91e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—prostate cancer	8.27e-07	5.82e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CREBBP—prostate cancer	8.23e-07	5.79e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—INS—prostate cancer	7.83e-07	5.51e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—prostate cancer	7.8e-07	5.49e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CREBBP—prostate cancer	7.67e-07	5.39e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NOS3—prostate cancer	7.37e-07	5.18e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—prostate cancer	7.27e-07	5.11e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NOS3—prostate cancer	6.87e-07	4.83e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—prostate cancer	6.8e-07	4.78e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—prostate cancer	6.74e-07	4.74e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—prostate cancer	6.61e-07	4.65e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—prostate cancer	6.34e-07	4.46e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—prostate cancer	6.28e-07	4.42e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—prostate cancer	5.88e-07	4.13e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—EP300—prostate cancer	5.6e-07	3.94e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—prostate cancer	5.48e-07	3.85e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—prostate cancer	5.4e-07	3.8e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—EP300—prostate cancer	5.22e-07	3.67e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—prostate cancer	4.15e-07	2.92e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—prostate cancer	3.86e-07	2.72e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—prostate cancer	3.39e-07	2.38e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—prostate cancer	3.16e-07	2.22e-06	CbGpPWpGaD
